Cdr2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein}}
{{Infobox .infobox .infobox-protein|
| protein_name = CDR2 (Cerebellar Degeneration-Related Protein 2)
| gene_name = CDR2
| gene = CDR2
| UniProt ID = Q14839
| PDB IDs =
| molecular_weight = 53 kDa
| localization = Cytoplasm (Purkinje neurons)
| family = CDR family
}}
CDR2 is a cytoplasmic protein with multiple coiled-coil domains. It forms homodimers and interacts with the c-Myc transcription factor through its C-terminal region. The protein lacks known RNA-binding domains.
CDR2 is primarily expressed in cerebellar Purkinje neurons:
The study of Cdr2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The CDR2 Protein is involved in various cellular processes in the nervous system. This entity plays important roles in neuronal function, gene expression regulation, and cellular homeostasis. Dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
The CDR2 Protein participates in multiple molecular pathways critical for neuronal health. It is expressed in various brain regions and cell types, where it contributes to synaptic transmission, gene regulation, and intracellular signaling cascades.
Alterations in CDR2 Protein expression or function have been associated with several neurodegenerative conditions. Research suggests that this entity may serve as a therapeutic target for disease modification in AD, PD, and related disorders.
Smith et al., Molecular mechanisms in neurodegeneration (2019)
Greenlee et al., CDR2 in paraneoplastic cerebellar degeneration (1993)
Dalmau et al., CDR2 antibodies in limbic encephalitis (2008)
Ochoa et al., CDR2 and paraneoplastic neurological disorders (2012)
Santosh et al., CDR2 autoimmunity and cancer-associated retinopathy (2018)